| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q4 2016 Pre-Market | EPS: REV: | -0.00 944.714M | |||
| Q2 2016 Pre-Market | EPS: REV: | -0.00 944.714M | -0.00 420.212M | ||
| Q4 2015 Pre-Market | EPS: REV: | 0.05 1.024B | -0.00 944.714M | ||
| FY 2014 Pre-Market | EPS: REV: | -1.24 940.2M | 0.05 1.024B | ||
| FY 2013 Pre-Market | EPS: REV: | 43.6M | -0.14 961M |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Is Now The Time To Buy Stock In American Airlines, Carnival, Tesla Or GE?
- The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
- Mid-Afternoon Market Update: Dow Surges Over 100 Points; Provention Bio Shares Plunge
- KushCo Q2 Revenue Increases 23% QoQ Ahead Of Merger With Greenlane
- Mid-Day Market Update: WD-40 Drops After Weak Q2 Results; Celcuity Shares Jump
- 5 Value Stocks In The Basic Materials Sector
- Overview Of Value Stocks In The Consumer Defensive Sector
- Simulations Plus's Earnings: A Preview
- Mid-Morning Market Update: Markets Open Higher; US Producer Prices Rise 1% In March
- What's Going On With GLSI Stock And PSMT Stock Today?
